Associate Professor, Medicine, UCLA School of Medicine
Nephrology
Dr. Suphamai Bunnapradist, MD
|
|
Give Review
Suphamai Bunnapradist is an expert in the field of Nephrology. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Suphamai Bunnapradist, MD has written publications. He has 102 publications published with PubMed. The lastest paper is: 'Acidic, pyruvate-based peritoneal dialysis solutions: relationship between low titratable acidity and biocompatibility.' He accepts Medicare.
Publications
- Renal Dysfunction in End-Stage Liver Disease and Post-Liver Transplant.
- Incidence of Conversion to Active Waitlist Status Among Temporarily Inactive Obese Renal Transplant Candidates.
- Bone and mineral disorders after Kidney transplantation: Therapeutic strategies.
- Can aminotransferase to platelet ratio index and other non-invasive markers effectively reduce liver biopsies for Renal transplant evaluation of hepatitis C virus-posi...
- Conversion from twice-daily tacrolimus to once-daily extended release tacrolimus (LCPT): the phase III randomized MELT trial.
- The impact of pre-transplant dialysis on simultaneous pancreas-Kidney versus living donor Kidney transplant outcomes.
- Improved survival among sickle cell Kidney transplant recipients in the recent era.
- Donor race and outcomes in Kidney transplant recipients.
- Posttransplant Malignancies in Solid Organ Adult Recipients: An Analysis of the U.S. National Transplant Database.
- Zero-Mismatch Deceased-Donor Kidney Versus Simultaneous Pancreas-Kidney Transplantation.
- Timing of dialysis initiation in transplant-naive and failed transplant patients.
- Use of the organ donor With prior hepatitis B infection: a safe option?
- Hepatitis C therapy With long term remission after renal transplantation.
- Comorbidity assessment in hemodialysis and peritoneal dialysis using the index of coexistent Disease.
- The role of cytokines and cytokine gene polymorphism in T-cell activation and allograft rejection.
- Acidic, pyruvate-based peritoneal dialysis solutions: relationship between low titratable acidity and biocompatibility.
- Treatment of HCV-related liver Diseases after renal transplantation: modern views.
- HCV-associated renal Diseases after liver transplantation.
- Intravenous Immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recip...
- Meta-analysis: Effect of Hepatitis C virus infection on mortality in dialysis.
- Meta-analysis: the effect of age on immunological response to hepatitis B vaccine in end-stage renal Disease.
- Epidemiology and clinical significance of hepatotropic infections in dialysis patients. Recent evidence.
- Meta-analysis: interferon for the treatment of Chronic hepatitis C in dialysis patients.
- Controlling treatment allocation bias in a registry analysis when comparing calcineurin inhibitors.
- Transplanting solid organs from HBsAg negative donors positive for antibody to Hepatitis B core antigen: the implications.
- Multivariate analysis of antibody induction therapy and their associated outcomes in deceased donor transplants.
- Multivariate analysis of the effectiveness of using antibody induction therapy according to the degree of HLA mismatches.
- Lamivudine in the treatment of HBV-related liver Disease after renal transplantation: an update.
- Successful use of oral ganciclovir for the treatment of intrauterine cytomegalovirus infection in a Renal allograft recipient.
- Pulsatile perfusion reduces the incidence of delayed graft function in expanded criteria donor Kidney transplantation.
- Meta-analysis: the dialysis mode and immunological response to Hepatitis B virus vaccine in dialysis population.
- Effect of induction therapy protocols on transplant outcomes in crossmatch positive renal allograft recipients desensitized With IVIG.
- The onset of rapidly progressive neurologic deterioration after a brief gastrointestinal illness in a Renal allograft recipient.
- A retrospective analysis of immunosuppression compliance, dose reduction and discontinuation in Kidney transplant recipients.
- Overview of Renal transplantation.
- Factors associated with discard of recovered Kidneys.
- Can machine perfusion decrease the likelihood of discard among biopsied Kidneys?
- Predictive ability of pretransplant comorbidities to predict long-term graft loss and death.
- Associations of pretransplant serum albumin with post-transplant outcomes in Kidney transplant recipients.
- Associations of body mass index and weight loss With mortality in transplant-waitlisted maintenance hemodialysis patients.
- Outcomes of simultaneous heart-Kidney transplant in the US: a retrospective analysis using OPTN/UNOS data.
- Does the Use of mTOR Inhibitors Increase Long-Term Mortality in Kidney Recipients?
- Effects of Antibody Induction on Transplant Outcomes in Human Leukocyte Antigen Zero-Mismatch Deceased Donor Kidney Recipients.
- Dialysis modality and outcomes in Kidney transplant recipients.
- Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in Kidney transplant recipients.
- Management of Renal dysfunction in patients receiving a liver transplant.
- Outcomes of preemptive Kidney with or without subsequent pancreas transplant compared with preemptive simultaneous pancreas/Kidney transplantation.
- Impact of pre-existing hepatitis B infection on the outcomes of Kidney transplant recipients in the United States.
- Higher recipient body mass index is associated with post-transplant delayed Kidney graft function.
- Transplantation: Donor risk scores: can they predict Renal transplant outcomes?
- Induction immunosuppressive therapy in the elderly Kidney transplant recipient in the United States.
- Living donor Kidney versus simultaneous pancreas-Kidney transplant in type I diabetics: an analysis of the OPTN/UNOS database.
- Fluid retention is associated With cardiovascular mortality in patients undergoing long-term hemodialysis.
- Kidney transplant outcomes in patients with Fabry disease.
- Outcomes of simultaneous pancreas-Kidney transplantation in type 2 diabetic recipients.
- Associations of Pretransplant Weight and Muscle Mass With Mortality in Renal Transplant Recipients.
- Risk factors for development of new-onset Diabetes mellitus after transplant in adult lung transplant recipients.
- Cause of death With graft function among renal transplant recipients in an integrated healthcare system.
- Pretransplant risk factors for new-onset Diabetes mellitus after transplant in pediatric liver transplant recipients.
- Kidney transplants for the elderly: hope or hype?
- Associations of pretransplant diabetes mellitus, new-onset diabetes after transplant, and Acute rejection with transplant outcomes: an analysis of the Organ Procuremen...
- Cytomegalovirus serostatus pairing and deceased donor Kidney transplant outcomes in adult recipients with antiviral prophylaxis.
- Intermediate-term outcomes associated with Kidney transplantation in recipients 80 years and older: an analysis of the OPTN/UNOS database.
- Induction therapy in pediatric Kidney transplant recipients discharged with a triple drug immunosuppressive regimen.
- Influence of preexisting hepatitis C virus antibody positivity in simultaneous pancreas-Kidney transplant recipients.
- Risk factors for development of new-onset Diabetes mellitus in adult heart transplant recipients.
- Pancreas after living donor Kidney versus simultaneous pancreas-Kidney transplant: an analysis of the organ procurement transplant network/united network of organ shar...
- Outcomes of renal transplantation in recipients With Wegener''s granulomatosis.
- Risk factors for new-onset Diabetes mellitus in adult liver transplant recipients, an analysis of the Organ Procurement and Transplant Network/United Network for Organ...
- Risk factors for development of new-onset Diabetes mellitus in pediatric renal transplant recipients: an analysis of the OPTN/UNOS database.
- Obesity was associated with inferior outcomes in simultaneous pancreas Kidney transplant.
- Transplantation with pancreas after living donor Kidney vs. living donor Kidney alone in type 1 diabetes mellitus recipients.
- Alemtuzumab versus interleukin-2 receptor antibodies induction in living donor Kidney transplantation.
- Increasing incidence of new-onset Diabetes after transplant among pediatric renal transplant patients.
- Transplantation: To convert or not to convert: lessons from the CONVERT trial.
- Transplant tourism in the United States: a single-center experience.
- Impact of gastrointestinal-related side effects on mycophenolate mofetil dosing and potential therapeutic strategies.
- The evolving notion of "senior" Kidney transplant recipients.
- Immunosuppression in Renal transplantation: some aspects for the modern era.
- Outcomes of Kidney transplantation from older living donors to older recipients.
- Expanding the evidence base in transplantation: the complementary roles of randomized controlled trials and outcomes research.
- Patient and graft outcomes from deceased Kidney donors age 70 years and older: an analysis of the Organ Procurement Transplant Network/United Network of Organ Sharing ...
- Multicenter, randomized study of the use of everolimus With tacrolimus after renal transplantation demonstrates its effectiveness.
- Incidence and risk factors for diarrhea following Kidney transplantation and association with graft loss and mortality.
- Outcomes of dual adult Kidney transplants in the United States: an analysis of the OPTN/UNOS database.
- Donor biopsy and Kidney transplant outcomes: an analysis using the Organ Procurement and Transplantation Network/United Network for Organ Sharing (OPTN/UNOS) database.
- Is there a reversal of reverse epidemiology in Renal transplant recipients?
- Alemtuzumab induction in deceased donor Kidney transplantation.
- Immunosuppression of the elderly Kidney transplant recipient.
- Safety and adverse events profiles of intravenous gammaglobulin products used for immunomodulation: a single-center experience.
- Minimizing ciclosporin in Renal transplant recipients on daclizumab, mycophenolate and steroids.
- Alemtuzumab induction in Kidney transplantation.
- Application of diagnostic classification algorithms to identify the most common causes of post-transplant complications.
- Health insurance considerations for adolescent transplant recipients as they transition to adulthood.
- Allocating deceased donor Kidneys: maximizing years of life.
- Risk factors for development of new-onset diabetes mellitus after Kidney transplantation.
- Outcomes of renal transplantation for recipients With lupus nephritis: analysis of the Organ Procurement and Transplantation Network database.
- Does plasmapheresis desensitize Kidney transplant recipients more effectively than high-dose immunoglobulin?
- Mycophenolate mofetil dose reductions and discontinuations after gastrointestinal complications are associated with renal transplant graft Failure.
- Effect of diabetes and Acute rejection on liver transplant outcomes, an analysis of the OPTN/UNOS database.
- Simultaneous liver-Kidney transplantation or liver transplantation alone for patients in need of liver transplantation with renal dysfunction.
Schools
Chulalongkorn University
Procedures Preformed
- Hemodialysis
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Calcium Metabolism Disorders
- Chronic Glomerulonephritis
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
UCLA Medical Center -
Tufts Medical Center -
Chulalongkorn University Faculty of Medicine
Hospital
-
Ronald Reagan UCLA Medical Center
Drug Facts
| NPI NUMBER | 1821076639 | |
| NPPES Provider LastName | BUNNAPRADIST | |
| NPPES Provider FirstName | SUPHAMAI | |
| NPPES Provider ZIPCode | 900481865 | |
| NPPES Provider State | CA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 1713.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 43.0 | |
| Percent Opioid Claims | 2.51 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1821076639 |
| Last Name Of The Provider | BUNNAPRADIST |
| First Name Of The Provider | SUPHAMAI |
| View All |
Similar Doctors
|
|
Dr. David L. Hartenbower, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susana M. Mendoza, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anjay Rastogi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ankit V. Shah, MD |
|
Dr. Elsa M. Aguiniga, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph Cha, MD |
|
|
Dr. Iris Lee, MD |
|
|
Dr. Suma Raju, MD |
|
|
Dr. John I. Sam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thuc B. Tu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pinky V. Patel, MD |